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Abstract: In the past years an increasing number of graphical user interfaces for Molecular Dynamics (MD) were presented and 
concomitantly, more and more Molecular Dynamics studies were published. With the easier application of MD software packages the 
field runs the risk however, of being pervaded with unreliable results. Therefore, possible benefits and caveats have to be carefully 
balanced. Here we outline in which respects a broader access of MD via graphical user interfaces may help to increase the usability of 
Molecular Dynamics simulations while maintaining their quality.
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Molecular  Dynamics1  (MD)  is  a  computational 
technique  which  solves  Newton’s  equations  of 
motion  to  predict  the  movements  of  atoms  within 
molecules  over  time.  This  technique  can  give 
insights into spatial arrangement of systems where 
experimental approaches fail due to limited resolution 
(electron  tomography),  demanding  and  unfeasible 
crystallisation  (x-ray  crystallography),  or  limited 
size (NMR). Furthermore, MD provides the spatial 
dynamics of a system over time, giving new insights 
and appreciations of molecular functions relevant to 
biological processes such as, e.g. T cell activation.2,3
To supply MD to a broader audience, graphical 
user interfaces (GUIs) are developed. Such GUIs exist 
for CHARMM,4 e.g. the web-based CHARMM-GUI5 
providing a membrane builder, or also CHARMMing,6 
including  additional  programs  to  define  structures 
not  supported  by  standard  CHARMM  and  a  job 
manager for grid computing. For the AMBER7 MD 
package the software Glycam Biomolecule Builder8 
is  available,  allowing  to  build  new  biomolecules 
and directly submit them to AMBER. For the MD 
Software  NAMD9  the  NAMD-GUI10  is  provided 
as plug-in for the 3D viewer VMD.11 Also for the 
GROMACS12 MD package different GUIs exist: For 
example, jSimMacs13 is a Java implementation and 
provides an interactive 3D representation and remote 
access capability for MD simulations. GROMITA14 
is  a  cross-platform  perl/tcl-tk  based  solution, 
GUIMACS15 is Java based and GROMACS-GUI16 is 
developed in C++. For a detailed comparison between 
GROMACS GUIs see Roopra et al.13
Using one of them, scientists even without technical 
background  and  Linux  command  line  knowledge 
are able to perform MD and thereby support their 
research  with  additional  data  on  structures  and 
functions. However, this leads to a fundamental issue: 
With MD methods becoming more and more easy to 
handle, fast and freely accessible, a growing audience 
of researchers will come in contact with the field, as 
indicated by the increasing number of publications in 
MD (see Fig. 1). Some of those simulations may be 
carried out by “trial and error”, clicking on buttons 
until  the  simulation  starts  somehow.  Such  lack  of 
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Figure 1. number of published mD papers per year. Data based on Pubmed search in July 2009.Graphical user interfaces for molecular dynamics—quo vadis?
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sound knowledge about what is really calculated in 
background  may  lead  to  incorrect  settings  and/or 
results: insufficient time for energy minimisation and 
position restraining, too short cut offs, water shells 
with inappropriate sizes et cetera. These and many 
more parameters need to be carefully chosen for each 
system.17  Otherwise,  unreliable  and  irreproducible 
simulations  may  result,  which  run  the  risk  of 
endangering the scientific reputation of the field.
One  could  argue  that  the  peer  review  system 
should be able to spot and filter out such publications. 
However, this may be wishful thinking since most 
reviewers  will  concentrate  on  the  manuscript  only 
and  not  examine  the  original  data  or  background 
information for reasons of time. For experts in MD, 
weaknesses in the description of methods etc. would 
still be noticeable and they might ensure clarification. 
However, as MD becomes “just a tool”, all reviewers 
of  a  paper  (using  MD  among  other  methods) 
might have a “biomedical” focus and lack personal 
expertise in MD. In such a case, results might pass 
review as long as they look plausible and fit into the 
picture, even if serious questions regarding reliability 
would  be  appropriately  tackled.  Hence,  there  are 
opinions in the community which entirely decline the 
development of any kind of graphical user interface, 
following the ulterior reasoning that the additional 
barrier  of  command  line  handling  may  keep  off 
inexperienced  users  from  MD  techniques.  By  this 
way only researchers willing to invest time and effort 
in learning the ropes of MD will be able to carry out 
simulations.
It is obvious that researchers able to perform MD 
properly from a command line level may also use 
GUIs: they know “what is going on behind the scene” 
and  may  still  benefit  from  easier  handling  (select 
instead of type, no miss-typing, automatic naming of 
serial files etc. (if it is a really potent GUI). Users 
approaching solely via the GUI at any rate run a higher 
risk. From the authors’ point of view, in order to curb 
that risk, four major perspectives should be discussed 
by the community, as itemized in the following (and 
formulated as guidelines in Box 1 and Box 2):
1. For  all  kinds  of  simulations  standardized  and 
exchangeable parameter files (e.g. in XML-format) 
should  be  provided  with  each  submission. 
Supplying such files it will be visible at a glance 
what was done in the simulation and disguising 
of  grubby  settings  will  not  be  possible.  For 
more  complex  situations  even  virtual  machines 
containing all necessary environment parameters 
could be provided. GUIs could output such files. 
Similar  ideas,  however  for  much  more  general 
purposes, were already put forward.18
2. Expert  systems  could  be  implemented  in 
MD-GUIs  to  guide  the  inexperienced  user  and 
help to avoid wrong decisions. Similar thoughts 
were suggested by an anonymous reviewer to one 
of  our  manuscripts.  These  systems  could  even 
learn  from  past  parameter  settings  which  have 
led to exploding, crashing or hang up simulation 
runs. However, it seems obvious that such systems 
can never fully replace a cautious and reflective 
human.
3. Repetitive  MD  simulations  of  the  same  system 
(using slightly different initial forces) can help to 
sample an extended part of the solution space (up to 
thousands of ns in total), avoid random errors and 
yield results more reliable due to more sufficient 
sampling.
4. Whenever MD is applied to a molecular system 
where it has not yet reached the phase of mature and 
routinely performed work but is still investigative 
in  character,  MD  results  published  should  be 
supported  and/or  matched  with  experimental 
data. This will help reviewers to decide whether 
a  simulation  is  reliable  or  not.  In  this  context 
experimental data does not necessarily mean x-ray 
crystallography or NMR. Also binding studies or 
observed  immunological  processes  may  support 
MD results.2,3 However, if no experimental data is 
available, it may also be an opportunity to employ 
other computational methods such as normal mode 
analysis (NMA) to validate MD results.19
Along  these  lines  molecular  dynamics—also  if 
run via GUIs—will come of age and find its place as 
standard technique in wet laboratories. There it will 
complement and—may be in future—replace parts of 
the experiments.
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Box 1: Guidelines and questions part 1: how inexperienced users can assure reliable
simulations, when not using GUIs.
Does a mailing list exist to get in contact with more experienced users? Use it. 
Are there any tutorials provided by the authors of the mD package? Are training 
courses offered? 
run test simulations to get familiar with the package and to obtain valid parameter 
sets (e.g. as reported by omasits et al17.)
Do changes in parameters affect the results e.g. size of water shell, interaction cut 
offs? Are there default parameter files available which can be exchanged in a 
standardized format? (see also text, item 1) 
If one repeats the simulations using slightly different initial forces, are the results after 
equilibration similar? (item 3) 
how does my parameter file look like compared to the ones provided by other 
research groups? (item 1) 
Is there knowledge available about crashed simulations? how can this outcome be 
avoided? (item 2) 
Are additional computational techniques such as nmA appropriate to validate my 
system? (item 4) 
Is there experimental data in the literature or available from co-operation partners 
which support my simulation findings? (item 4) 
Functional reliability of outcome 
Technical reliability 
Box 1. Guidelines and questions part 1: how inexperienced users can assure reliable simulations, when not using GUIs.
Box 2: Guidelines and questions part 2: how inexperienced users can assure reliable
simulations, when using GUIs.   
make sure that you are familiar with meaning, effects and appropriate setting of
simulation parameters and options from the documentation of the mD package itself
(see also Box 1).  
If a tutorial of the GUI is available, work  through it, reproduce model simulations if
provided by the authors of the GUI.  
Check how your settings via the GUI affect the underlying parameter files produced
by the GUI and submitted to the mD package, compare parameter files to reference
settings as suggested above.  
Box 2. Guidelines and questions part 2: how inexperienced users can assure reliable simulations, when using GUIs.Graphical user interfaces for molecular dynamics—quo vadis?
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